SUNDYS: A Multicenter, Randomized, Double-blind, Sham-controlled, Parallel-group Trial (SUNDYS)
Dystonia
About this trial
This is an interventional treatment trial for Dystonia focused on measuring Deep brain stimulation, Subthalamic nucleus, Randomized controlled trial
Eligibility Criteria
Inclusion Criteria:
- Patients must meet criteria for the diagnosis of isolated generalized or segmental dystonia, including idiopathic and inherited dystonia, as defined by the Phenomenology and Classification of Dystonia: A Consensus Update 2013;
- Patients will be ≥ 14 years old;
- The course of disease will be ≥ 3 years;
Patients will have:
- Significant dystonia symptoms;
- Compromised life quality;
- Unsatisfactory response to oral treatment with anticholinergic agents antiepileptic agents, anti-dopamine agents, dopaminergic agents, or muscle relaxants;
- Unsatisfactory response to or contraindication for previous botulinum toxin treatment; and
- Ability to provide written informed consent.
Exclusion Criteria:
- Patients with a diagnosis or probable diagnosis of acquired, compound, and complex dystonia, as defined by the Phenomenology and Classification of Dystonia: A Consensus Update 2013;
- Previous brain surgery for dystonia;
- Patients with cognitive impairment (MMSE score <24) or moderate-severe depressive disorder (BDI>25);
- Patients with marked brain atrophy identified by magnetic resonance imaging (MRI) or computed tomography (CT);
- Patients with other medical or psychiatric comorbidities that could increase the surgical risk or interfere with completion of the trial;
- Patients with increased bleeding risk, or other factors contraindicating neurosurgery or general anesthesia;
- Patients unable to cooperate with the assessments during the follow-up.
Sites / Locations
- Shanghai Ruijin HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Active Comparator
Sham Comparator
STN DBS stimulation group
Sham stimulation group
In the STN DBS stimulation group, patients will receive a continuous DBS stimulation for 3 months and the first default parameters applied will be monopolar setting (0.5 V under threshold that causes side effects, 135 Hz, 90 µs, at one of the two dorsal contacts). If the default parameters are found not suitable for an individual patient due to unexpected reasons, an alternative method will be applied (e.g., decreased voltage) to try to maintain full compliance with the scheduled study.
In the sham stimulation group, the programming will also start within 1 week after the surgery, but at each follow-up the DBS system will be turned off after the parameter is adjusted to the threshold that causes side effects without continuous stimulation. After the 3-month double-blind period the patients can choose to set on the DBS system again and receive regular continuous stimulation treatment.